Key result
Rural residence was associated with a higher prevalence of chronic heart failure compared to metropolitan areas (16.1% vs 12.4%, P<0.001) and lower use of recommended diagnostic methods and treatments.
Why the study?
Does primary care management of chronic heart failure differ between rural and urban areas in Australia?
Cross-Sectional (n=23,845)
Yes
Does primary care management of chronic heart failure differ between rural and urban areas in Australia?
Absolute Event Rate: 16.1% vs 12.4%
p-value: p=<0.001
Rural patients with chronic heart failure in Australia experience higher disease prevalence but receive less evidence-based diagnostic and pharmacological management compared to urban patients.
Rural disparities in heart failure care warrant attention; Level 4 data leaves open causal factors and intervention effects.
OBJECTIVE: To determine whether primary care management of chronic heart failure (CHF) differed between rural and urban areas in Australia. DESIGN: A cross-sectional survey stratified by Rural, Remote and Metropolitan Areas (RRMA) classification. The primary source of data was the Cardiac Awareness Survey and Evaluation (CASE) study. SETTING: Secondary analysis of data obtained from 341 Australian general practitioners and 23 845 adults aged 60 years or more in 1998. MAIN OUTCOME MEASURES: CHF determined by criteria recommended by the World Health Organization, diagnostic practices, use of pharmacotherapy, and CHF-related hospital admissions in the 12 months before the study. RESULTS: There was a significantly higher prevalence of CHF among general practice patients in large and small rural towns (16.1%) compared with capital city and metropolitan areas (12.4%) (P < 0.001). Echocardiography was used less often for diagnosis in rural towns compared with metropolitan areas (52.0% v 67.3%, P < 0.001). Rates of specialist referral were also significantly lower in rural towns than in metropolitan areas (59.1% v 69.6%, P < 0.001), as were prescribing rates of angiotensin-converting enzyme inhibitors (51.4% v 60.1%, P < 0.001). There was no geographical variation in prescribing rates of beta-blockers (12.6% [rural] v 11.8% [metropolitan], P = 0.32). Overall, few survey participants received recommended "evidence-based practice" diagnosis and management for CHF (metropolitan, 4.6%; rural, 3.9%; and remote areas, 3.7%). CONCLUSIONS: This study found a higher prevalence of CHF, and significantly lower use of recommended diagnostic methods and pharmacological treatment among patients in rural areas.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2007) conducted a cross-sectional in Chronic heart failure (n=23,845). Rural residence vs. Metropolitan residence was evaluated on Prevalence of chronic heart failure (p=<0.001). Rural residence was associated with a higher prevalence of chronic heart failure compared to metropolitan areas (16.1% vs 12.4%, P<0.001) and lower use of recommended diagnostic methods and treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: